Analyst Ratings for AstraZeneca (AZN)
AZN Rating Summary
AZN Price Target Summary
- Highest: $66.00 (Cowen)
- Lowest: $61.50 (Jefferies)
- Average: $64.17
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$64.17 (+16.2%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 64%
Avg. $ Target:
$64.17 (+16.2%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 64%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/12/2021 | Argus » Updated 4/14/2021 |
John Eade | Downgrade | Hold (Buy) |
N/A (N/A) |
49.94 (55.21) |
10.55% | Details |
| 3/16/2021 | Jefferies | Ian Hilliker | Upgrade | Buy (Hold) |
61.50 (56.00) |
48.77 (55.21) |
13.2% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
